한국유니온제약(주)

ETC

Neonypol Vaginal Soft Cap.

Active Ingredients: Nystatin 100000 IU + Neomycin Sulfate 50.2mg + Polymixin B Sulfate 35000 IU

Indications: Vaginal candidiasis, non-specific bacterial vaginitis, vulvitis, and purulent leukorrhea due to stomach disease

Gastrointestinal

Newcota Tab.

Active Ingredients: Rebamipide 100mg

Indications: 1. Gastric ulcer 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) of the following diseases: Acute exacerbation of acute gastritis and chronic gastritis

ETC

Newlocam Cap.

Active Ingredients: Meloxicam 7.5mg

Indications: 1. Treatment of short-term symptoms in acute exacerbation of osteoarthritis with ataxia of pain 2. Symptomatic treatment of rheumatoid arthritis over a long period of time 3. Symptomatic treatment of ankylosing spondylitis

Gastrointestinal

Pobutin Tab.

Active Ingredients: Trimebutine Maleate 150mg

Indications: 1. Digestive dysfunction in esophageal reflux and hiatus hernia, gastroduodenitis, gastric duodenal ulcer (stomach pain, indigestion, nausea, vomiting) 2. Irritable bowel syndrome and spastic colon 3. Pediatric disease: habitual vomiting, non-infectious intestinal transit disorder (constipation, diarrhea), stimulation of shaking, sleep disorder

ETC

Procin Eye Drops

Active Ingredients: Levofloxacin Hydrate 5mg/mL

Indications: 1. Effective species Staphylococcus, streptococcus, pneumococcus, micrococcus, enterococci, corynebacterium, pseudomonas, stenotropomonas (santomonas) maltophilia, pseudomonas aeruginosa, haemophilus [haemophilus influenzae, haemophilus aegyptius (Koch-Weeks)], moraxella, ceratia, klebsiella, proteus, morganella morgani, acinetobacter, enterobacter, acne bacteria 2. Indications Blepharitis, erythroma, folliculitis, conjunctivitis, scleritis, keratitis, corneal ulcer, aseptic therapy during ophthalmic surgery

Antibiotics

Procin Inj.

Active Ingredients: Levofloxacin Hydrate 5mg/mL

Indications: 1. Effective species Enterococci, staphylococcus aureus, streptococcus pneumoniae, streptococcus pyogenes, enterobacter cloaca, E. coli, haemophilus influenza, haemophilus parainfluenza, pneumococcal bacillus, moraxella catarrhalis, proteus mirabilis, pseudomonas aeruginosa, ceratia marsense, chlamydia pneumoniae, legionella pneumoniae, mycoplasma pneumoniae 2. Indications 1) Community-infected pneumonia 2) Complex urinary tract infections, including acute pyelonephritis 3) Infections of skin and soft tissues 4) Acute sinusitis 5) Acute bacterial exacerbation of chronic bronchitis Fluoroquinolone-based drugs, including THIS DRUG, are associated with serious adverse events, so acute bacterial deterioration of acute bacterial sinusitis and chronic bronchitis should be used in patients who have no other treatment options.

ETC

Ratrol Inj.

Active Ingredients: Tramadol HCl 50mg/mL / Tramadol HCl 100mg/2mL

Indications: 1. Severe and moderate acute pain (various cancers) 2. Diagnosis and post-operative pain

ETC

Rosutatin Tab. 10mg

Active Ingredients: Rosuvastatin 10mg

Indications: 1. Primary hypercholesterolemia (type Ⅱa including heterozygous familial hypercholesterolemia), complex hyperlipidemia (type Ⅱb): Dietary supplements if they cannot be controlled by diet and exercise 2. Adjuvant of diet or other lipid-lowering therapy (eg, LDL separation) for homozygous familial hypercholesterolemia 3. Delayed progression of atherosclerosis in patients with hypercholesterolemia by lowering total cholesterol and LDL-cholesterol to target levels 4. Dierary supplements to reduce chloesterol, LDL-cholesterol and Apo-B protein levels in patients aged 10 ~ 17 years (female at least one year after menarche) with heterozygous family hypercholesterolemia, which still meets the following criteria, despite the diet 1) LDL-cholesterol still exceeds 190 mg/dL (LDL-C>190 mg/dL) 2) LDL-cholesterol still exceeds 160 mg/dL (LDL-C>160 mg/dL), with a family history of early cardiovascular disease or at least two cardiovascular disease risk factors 5. Dietary supplements in patients with primary abnormal betalipoproteinemia (type III) 6. Reduced risk of cardiovascular disease: There is no clinical evidence of coronary heart disease, but men over 50 years of age and women over 60 years of age have a high sensitivity of C-reactive protein (hsCRP) of 2 mg/L and at least one additional cardiovascular risk factor (eg, high blood pressure, low HDL-cholesterol levels, smoking, or family history of early coronary heart disease); 1) Reduced risk of stroke 2) Reduced risk of myocardial infarction 3) Reduced risk of arterial angioplasty

한국유니온제약(주)

Product Information

All